- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2012 (2012), Article ID 820254, 12 pages
Putative Multifunctional Signature of Lung Metastases in Dedifferentiated Chondrosarcoma
1Cancer Biology and Epigenomics Program, Children’s Memorial Research Center, and Department of Pediatrics, Northwestern University Feinberg School of Medicine, 2430 N. Halstead Street, Chicago, IL 60614, USA
2GeneGo, Inc., 500 Renaissance Drive, No. 106, St. Joseph, MI 49085, USA
3Department of Pathology and Laboratory Medicine, Children’s Memorial Hospital 2300 Children’s Plaza, Chicago, IL 60614, USA
4Center for Bioinformatics and Computation Biology, University of Iowa, 5316 Seamans Center, Iowa City, IA 52242, USA
5Department of Orthopaedics and Rehabilitation, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA
6Vavilov Institute for General Genetics, Russian Academy of Sciences, 3 Gubkina Street, Moscow 117093, Russia
7Department of Urology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA
8Department of Hematology/Oncology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA
9Department of Surgical Pathology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA
10Lung Cancer and Thoracic Oncology Program, Beckman Research Institute, City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA
11Department of Pediatrics, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA
Received 12 May 2011; Revised 21 October 2011; Accepted 3 November 2011
Academic Editor: Alessandro Gronchi
Copyright © 2012 Sergey Malchenko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. A. Littrell, D. E. Wenger, L. E. Wold et al., “Radiographic, CT, and MR imaging features of dedifferentiated chondrosarcomas: a retrospective review of 174 De Novo cases,” Radiographics, vol. 24, no. 5, pp. 1397–1409, 2004.
- I. D. Dickey, P. S. Rose, B. Fuchs et al., “Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes,” Journal of Bone and Joint Surgery—Series A, vol. 86, no. 11, pp. 2412–2418, 2004.
- P. F. M. Choong and A. P. W. Nadesapillai, “Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis,” Clinical Orthopaedics and Related Research, no. 415, pp. S46–S58, 2003.
- J. V. M. G. Bovée, P. C. W. Hogendoorn, J. S. Wunder, and B. A. Alman, “Cartilage tumours and bone development: molecular pathology and possible therapeutic targets,” Nature Reviews Cancer, vol. 10, no. 7, pp. 481–488, 2010.
- J. Tolar, A. J. Nauta, M. J. Osborn et al., “Sarcoma derived from cultured mesenchymal stem cells,” Stem Cells, vol. 25, no. 2, pp. 371–379, 2007.
- A. B. Mohseny, K. Szuhai, S. Romeo et al., “Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2,” Journal of Pathology, vol. 219, no. 3, pp. 294–305, 2009.
- A. B. Mohseny and P. C. W. Hogendoorn, “Concise review: mesenchymal tumors: when stem cells go mad,” Stem Cells, vol. 29, no. 3, pp. 397–403, 2011.
- M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999.
- E. A. Seftor, P. S. Meltzer, D. A. Kirschmann et al., “Molecular determinants of human uveal melanoma invasion and metastasis,” Clinical and Experimental Metastasis, vol. 19, no. 3, pp. 233–246, 2002.
- M. De Fatima Bonaldo, G. Lennon, and M. B. Soares, “Normalization and subtraction: two approaches to facilitate gene discovery,” Genome Research, vol. 6, no. 9, pp. 791–806, 1996.
- V. E. Velculescu, L. Zhang, B. Vogelstein, and K. W. Kinzler, “Serial analysis of gene expression,” Science, vol. 270, no. 5235, pp. 484–487, 1995.
- K. Boon, E. C. Osório, S. F. Greenhut et al., “An anatomy of normal and malignant gene expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 17, pp. 11287–11292, 2002.
- M. Z. Man, X. Wang, and Y. Wang, “POWER_SAGE: comparing statistical tests for SAGE experiments,” Bioinformatics, vol. 16, no. 11, pp. 953–959, 2000.
- Y. Nikolsky, E. Kirillov, R. Zuev, E. Rakhmatulin, and T. Nikolskaya, “Functional analysis of OMICs data and small molecule compounds in an integrated “knowledge-based” platform,” Methods in Molecular Biology, vol. 563, pp. 177–196, 2009.
- M. B. Eisen, P. T. Spellman, P. O. Brown, and D. Botstein, “Cluster analysis and display of genome-wide expression patterns,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14863–14868, 1998.
- K. Gijsbers, M. Gouwy, S. Struyf et al., “GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors,” Experimental Cell Research, vol. 303, no. 2, pp. 331–342, 2005.
- D. F. Smith, E. Galkina, K. Ley, and Y. Huo, “GRO family chemokines are specialized for monocyte arrest from flow,” American Journal of Physiology, vol. 289, no. 5, pp. H1976–H1984, 2005.
- M. Resnati, M. Guttinger, S. Valcamonica, N. Sidenius, F. Blasi, and F. Fazioli, “Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect,” The EMBO Journal, vol. 15, no. 7, pp. 1572–1582, 1996.
- G. F. Weber and S. Ashkar, “Molecular mechanisms of tumor dissemination in primary and metastatic brain cancers,” Brain Research Bulletin, vol. 53, no. 4, pp. 421–424, 2000.
- L. Bingle, N. J. Brown, and C. E. Lewis, “The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies,” Journal of Pathology, vol. 196, no. 3, pp. 254–265, 2002.
- M. Van Dongen, N. D. L. Savage, E. S. Jordanova et al., “Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors,” International Journal of Cancer, vol. 127, no. 4, pp. 899–909, 2010.
- T. Fujiwara, J.-I. Fukushi, S. Yamamoto et al., “Macrophage infiltration predicts a poor prognosis for human ewing sarcoma,” American Journal of Pathology, vol. 179, no. 3, pp. 1157–1170, 2011.
- J. W. Pollard, “Tumour-educated macrophages promote tumour progression and metastasis,” Nature Reviews Cancer, vol. 4, no. 1, pp. 71–78, 2004.
- R. B. Jakobsen, A. Shahdadfar, F. P. Reinholt, and J. E. Brinchmann, “Chondrogenesis in a hyaluronic acid scaffold: comparison between chondrocytes and MSC from bone marrow and adipose tissue,” Knee Surgery, Sports Traumatology, Arthroscopy, vol. 18, no. 10, pp. 1407–1416, 2010.
- J. T. Hecht and E. H. Sage, “Retention of the matricellular protein SPARC in the endoplasmic reticulum of chondrocytes from patients with pseudoachondroplasia,” Journal of Histochemistry and Cytochemistry, vol. 54, no. 3, pp. 269–274, 2006.
- T. Dehne, C. Karlsson, J. Ringe, M. Sittinger, and A. Lindahl, “Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation,” Arthritis Research & Therapy, vol. 11, no. 5, article R133, 2009.
- M. C. Embree, T. M. Kilts, M. Ono et al., “Biglycan and fibromodulin have essential roles in regulating chondrogenesis and extracellular matrix turnover in temporomandibular joint osteoarthritis,” American Journal of Pathology, vol. 176, no. 2, pp. 812–826, 2010.
- L. B. Rozeman, L. Hameetman, T. van Wezel et al., “cDNA expression profiling of chondrosarcomas: ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade,” Journal of Pathology, vol. 207, no. 1, pp. 61–71, 2005.
- T. Sun, E. B. Hunziker, and T. I. Morales, “Subcellular distribution of the insulin-like growth factor (IGF) binding proteins (IGFBPs) 2 and 3 in articular chondrocytes,” Journal of Orthopaedic Research, vol. 26, no. 11, pp. 1421–1427, 2008.
- S. P. Grogan, A. Barbero, J. Diaz-Romero et al., “Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity,” Arthritis and Rheumatism, vol. 56, no. 2, pp. 586–595, 2007.
- D. L. Cecil and R. Terkeltaub, “Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes,” Journal of Immunology, vol. 180, no. 12, pp. 8378–8385, 2008.
- J. Kruegel, B. Sadowski, and N. Miosge, “Nidogen-1 and nidogen-2 in healthy human cartilage and in late-stage osteoarthritis cartilage,” Arthritis and Rheumatism, vol. 58, no. 5, pp. 1422–1432, 2008.
- R. Morello and F. Rauch, “Role of cartilage-associated protein in skeletal development,” Current Osteoporosis Reports, vol. 8, no. 2, pp. 77–83, 2010.
- A. Gomez-Brouchet, F. Mourcin, P. A. Gourraud et al., “Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma,” Human Pathology, vol. 41, no. 9, pp. 1220–1230, 2010.
- X. Tang, X. Lu, W. Guo et al., “Different expression of Sox9 and Runx2 between chondrosarcoma and dedifferentiated chondrosarcoma cell line,” European Journal of Cancer Prevention, vol. 19, no. 6, pp. 466–471, 2010.
- K. H. Hallor, J. Staaf, J. V. M. G. Bové et al., “Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors,” Clinical Cancer Research, vol. 15, no. 8, pp. 2685–2694, 2009.
- S. Söder, A. M. Oliveira, C. Y. Inwards, S. Müller, and T. Aigner, “Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma,” Pathology, vol. 38, no. 1, pp. 35–38, 2006.
- L. Huang, Y. Y. Cheng, L. T. C. Chow, M. H. Zheng, and S. M. Kumta, “Receptor activator of NF-κB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment,” Journal of Clinical Pathology, vol. 56, no. 2, pp. 116–120, 2003.
- C. G. Hackel, S. Krueger, and H. J. Grote Grote, “Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma,” Cancer, vol. 89, no. 5, pp. 995–1003, 2000.
- C. Häckel, B. Czerniak, A. G. Ayala, K. Radig, and A. Roessner, “Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma,” Cancer, vol. 79, no. 1, pp. 53–58, 1997.
- N. Koide, A. Nishio, T. Sato, A. Sugiyama, and S. I. Miyagawa, “Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus,” American Journal of Gastroenterology, vol. 99, no. 9, pp. 1667–1674, 2004.
- A. S. Payne and L. A. Cornelius, “The role of chemokines in melanoma tumor growth and metastasis,” Journal of Investigative Dermatology, vol. 118, no. 6, pp. 915–922, 2002.
- J. D. Hood and D. A. Cheresh, “Role of integrins in cell invasion and migration,” Nature Reviews Cancer, vol. 2, no. 2, pp. 91–100, 2002.
- A. Calvo, R. Catena, M. S. Noble et al., “Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis,” Oncogene, vol. 27, no. 40, pp. 5373–5384, 2008.
- M. Gulubova and T. Vlaykova, “Immunohistochemical assessment of fibronectin and tenascin and their integrin receptors α5β1 and α9β1 in gastric and colorectal cancers with lymph node and liver metastases,” Acta Histochemica, vol. 108, no. 1, pp. 25–35, 2006.
- L. A. Carver and J. E. Schnitzer, “Caveolae: mining little caves for new cancer targets,” Nature Reviews Cancer, vol. 3, no. 8, pp. 571–581, 2003.
- T. M. Williams and M. P. Lisanti, “Caveolin-1 in oncogenic transformation, cancer, and metastasis,” American Journal of Physiology, vol. 288, no. 3, pp. C494–C506, 2005.
- E. Hiendlmeyer, S. Regus, S. Wassermann et al., “Beta-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors,” Cancer Research, vol. 64, no. 4, pp. 1209–1214, 2004.
- J. R. Graff, J. A. Deddens, B. W. Konicek et al., “Integrin-linked kinase expression increases with prostate tumor grade,” Clinical Cancer Research, vol. 7, no. 7, pp. 1987–1991, 2001.
- S. Jothy, “CD44 and its partners in metastasis,” Clinical and Experimental Metastasis, vol. 20, no. 3, pp. 195–201, 2003.
- H. Kobayashi, M. Suzuki, N. Kanayama, T. Nishida, M. Takigawa, and T. Terao, “CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells,” International Journal of Cancer, vol. 102, no. 4, pp. 379–389, 2002.
- S. K. Akiyama, K. Olden, and M. Yamada, “Fibronectin and integrins in invasion and metastasis,” Cancer and Metastasis Reviews, vol. 14, no. 3, pp. 173–189, 1995.
- A. J. Minn, G. P. Gupta, P. M. Siegel et al., “Genes that mediate breast cancer metastasis to lung,” Nature, vol. 436, no. 7050, pp. 518–524, 2005.
- H. Saji, H. Nakamura, I. Awut et al., “Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues,” Annals of Thoracic and Cardiovascular Surgery, vol. 9, no. 5, pp. 295–300, 2003.
- B. E. Nicholson, H. F. Frierson, M. R. Conaway et al., “Profiling the evolution of human metastatic bladder cancer,” Cancer Research, vol. 64, no. 21, pp. 7813–7821, 2004.
- M. Ishii, C. Koike, A. Igarashi et al., “Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts,” Biochemical and Biophysical Research Communications, vol. 332, no. 1, pp. 297–303, 2005.
- M. Honczarenko, Y. Le, M. Swierkowski, I. Ghiran, A. M. Glodek, and L. E. Silberstein, “Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors,” Stem Cells, vol. 24, no. 4, pp. 1030–1041, 2006.
- C. D. Li, W. Y. Zhang, H. L. Li et al., “Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation,” Cell Research, vol. 15, no. 7, pp. 539–547, 2005.
- J. S. Park, H. Y. Kim, H. W. Kim et al., “Increased caveolin-1, a cause for the declined adipogenic potential of senescent human mesenchymal stem cells,” Mechanisms of Ageing and Development, vol. 126, no. 5, pp. 551–559, 2005.
- U. R. Goessler, K. Bieback, P. Bugert et al., “In vitro analysis of integrin expression during chondrogenic differentiation of mesenchymal stem cells and chondrocytes upon dedifferentiation in cell culture,” International Journal of Molecular Medicine, vol. 17, no. 2, pp. 301–307, 2006.
- S. Neuss, R. K. M. Schneider, L. Tietze, R. Knüchel, and W. Jahnen-Dechent, “Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots,” Cells Tissues Organs, vol. 191, no. 1, pp. 36–46, 2009.
- S. Boeuf, P. Kunz, T. Hennig et al., “A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma,” Journal of Pathology, vol. 216, no. 2, pp. 158–166, 2008.
- K. Kudoh, M. Ramanna, R. Ravatn et al., “Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray,” Cancer Research, vol. 60, no. 15, pp. 4161–4166, 2000.
- G. S. Watts, B. W. Futscher, R. Isett, M. Gleason-Guzman, M. W. Kunkel, and S. E. Salmon, “cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways,” Journal of Pharmacology and Experimental Therapeutics, vol. 299, no. 2, pp. 434–441, 2001.
- E. P. Buddingh, M. L. Kuijjer, R. A. J. Duim et al., “Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents,” Clinical Cancer Research, vol. 17, no. 8, pp. 2110–2119, 2011.
- L. L'Italien, M. Tanudji, L. Russell, and X. M. Schebye, “Unmasking the redundancy between Cdk1 and Cdk2 at G2 phase in human cancer cell lines,” Cell Cycle, vol. 5, no. 9, pp. 984–993, 2006.
- R. E. Gerszten, E. A. Garcia-Zepeda, Y. C. Lim et al., “MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions,” Nature, vol. 398, no. 6729, pp. 718–725, 1999.
- M. Gouwy, S. Struyf, J. Catusse, P. Proost, and J. Van Damme, “Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration,” Journal of Leukocyte Biology, vol. 76, no. 1, pp. 185–194, 2004.
- E. T. A. Fry, D. L. Mack, and B. E. Sobel, “The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators,” Thrombosis and Haemostasis, vol. 62, no. 3, pp. 909–916, 1989.